{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T18:57:11Z","timestamp":1794855431275,"version":"4.9.1"},"reference-count":98,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T00:00:00Z","timestamp":1668384000000},"content-version":"am","delay-in-days":348,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004431","name":"Fondation de France","doi-asserted-by":"publisher","award":["00086486"],"award-info":[{"award-number":["00086486"]}],"id":[{"id":"10.13039\/501100004431","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004718","name":"Universit\u00e9 de Toulouse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014184","name":"R\u00e9gion Midi-Pyr\u00e9n\u00e9es","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014184","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.atherosclerosis.2021.10.013","type":"journal-article","created":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T11:49:29Z","timestamp":1635940169000},"page":"30-38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["A historical view of estrogen effect on arterial endothelial healing: From animal models to medical implication"],"prefix":"10.1016","volume":"338","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1291-6879","authenticated-orcid":false,"given":"Rana","family":"Zahreddine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgane","family":"Davezac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Buscato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2943-0878","authenticated-orcid":false,"given":"Natalia","family":"Smirnova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel","family":"Laffargue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Henrion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5230-2797","authenticated-orcid":false,"given":"Marine","family":"Adlanmerini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Lenfant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2229-6300","authenticated-orcid":false,"given":"Jean-Fran\u00e7ois","family":"Arnal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coralie","family":"Fontaine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib1","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ijcard.2012.03.084","article-title":"Endothelial dysfunction following drug-eluting stent implantation: a systematic review of the literature","volume":"165","author":"Minami","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib2","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1093\/eurheartj\/ehaa623","article-title":"Covid-19 is, in the end, an endothelial disease","volume":"41","author":"Libby","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib3","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s11883-019-0810-x","article-title":"Effects of radiotherapy in coronary artery disease","volume":"21","author":"da Silva","year":"2019","journal-title":"Curr. Atherosclerosis Rep."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib4","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1253\/circj.CJ-08-1169","article-title":"Endothelial dysfunction: the first step toward coronary arteriosclerosis","volume":"73","author":"Vanhoutte","year":"2009","journal-title":"Circ. J."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib5","first-page":"III77","article-title":"The role of endothelial injury and platelet and macrophage interactions in atherosclerosis","volume":"70","author":"Ross","year":"1984","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib6","doi-asserted-by":"crossref","first-page":"5924234","DOI":"10.1155\/2016\/5924234","article-title":"Neoatherosclerosis after drug-eluting stent implantation: roles and mechanisms","volume":"2016","author":"Cui","year":"2016","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib7","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1161\/ATVBAHA.109.191221","article-title":"Estrogen receptors and endothelium","volume":"30","author":"Arnal","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"Suppl 1","key":"10.1016\/j.atherosclerosis.2021.10.013_bib8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/13697130902820006","article-title":"Estrogen receptor actions on vascular biology and inflammation: implications in vascular pathophysiology","volume":"12","author":"Arnal","year":"2009","journal-title":"Climacteric : the journal of the International Menopause Society"},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib9","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1161\/CIRCULATIONAHA.109.898445","article-title":"Endothelial estrogen receptor-alpha plays a crucial role in the atheroprotective action of 17beta-estradiol in low-density lipoprotein receptor-deficient mice","volume":"120","author":"Billon-Gales","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib10","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1161\/CIRCRESAHA.115.306416","article-title":"The activation function-1 of estrogen receptor alpha prevents arterial neointima development through a direct effect on smooth muscle cells","volume":"117","author":"Smirnova","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib11","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1161\/01.CIR.103.3.423","article-title":"Estradiol accelerates reendothelialization in mouse carotid artery through estrogen receptor-alpha but not estrogen receptor-beta","volume":"103","author":"Brouchet","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib12","first-page":"21","article-title":"The impact of estrogen receptor in arterial and lymphatic vascular diseases","author":"Fontaine","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib13","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.008950","article-title":"Predominant role of nuclear versus membrane estrogen receptor alpha in arterial protection: implications for estrogen receptor alpha modulation in cardiovascular prevention\/safety","volume":"7","author":"Guivarc'h","year":"2018","journal-title":"Journal of the American Heart Association"},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib14","first-page":"407","article-title":"Endothelial regeneration. Ii. Restitution of endothelial continuity","volume":"41","author":"Haudenschild","year":"1979","journal-title":"Lab. Invest."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib15","first-page":"568","article-title":"Endothelial regeneration. I. Quantitative analysis of initial stages of endothelial regeneration in rat aortic intima","volume":"38","author":"Schwartz","year":"1978","journal-title":"Lab. Invest."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib16","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1161\/01.RES.73.5.792","article-title":"Mouse model of arterial injury","volume":"73","author":"Lindner","year":"1993","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib17","first-page":"761","article-title":"Vascular wound healing and neointima formation induced by perivascular electric injury in mice","volume":"150","author":"Carmeliet","year":"1997","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib18","first-page":"H2822","article-title":"Estradiol accelerates endothelial healing through the retrograde commitment of uninjured endothelium","volume":"294","author":"Filipe","year":"2008","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib19","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ajpath.2020.10.001","article-title":"Mechanisms of endothelial regeneration and vascular repair and their application to regenerative medicine","volume":"191","author":"Evans","year":"2021","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib20","doi-asserted-by":"crossref","first-page":"5430","DOI":"10.1038\/s41598-018-23653-3","article-title":"A multi-step transcriptional cascade underlies vascular regeneration in vivo","volume":"8","author":"Shirali","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib21","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.stem.2018.07.011","article-title":"Endothelial regeneration of large vessels is a biphasic process driven by local cells with distinct proliferative capacities","volume":"23","author":"McDonald","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib22","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1002\/stem.1690","article-title":"Endothelial foxm1 mediates bone marrow progenitor cell-induced vascular repair and resolution of inflammation following inflammatory lung injury","volume":"32","author":"Zhao","year":"2014","journal-title":"Stem Cell."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib23","first-page":"438","article-title":"Smooth muscle cells-derived cxcl10 prevents endothelial healing through PI3K\u03b3 -dependent T cells response","volume":"116","author":"Lupieri","year":"2020","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib24","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1161\/CIRCRESAHA.120.317062","article-title":"Tamoxifen accelerates endothelial healing by targeting ER\u03b1 in smooth muscle cells","volume":"127","author":"Zahreddine","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib25","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1161\/01.CIR.95.7.1768","article-title":"Estradiol accelerates functional endothelial recovery after arterial injury","volume":"95","author":"Krasinski","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib26","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1161\/01.CIR.96.5.1624","article-title":"Estrogen restores endothelial cell function in an experimental model of vascular injury","volume":"96","author":"White","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib27","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1172\/JCI38291","article-title":"Non-nuclear e ER\u03b1 signaling promotes cardiovascular protection but not uterine or breast cancer growth in mice","volume":"120","author":"Chambliss","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib28","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1161\/CIRCRESAHA.115.306416","article-title":"The activation function-1 of ER\u03b1 prevents arterial neointima development through a direct effect on smooth muscle cells","volume":"117","author":"Smirnova","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib29","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1210\/endo.138.8.5354","article-title":"Estrogen and progesterone inhibit vascular smooth muscle proliferation","volume":"138","author":"Morey","year":"1997","journal-title":"Endocrinology"},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib30","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1161\/01.CIR.91.3.755","article-title":"Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and in a murine model","volume":"91","author":"Morales","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib31","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.mce.2010.06.020","article-title":"Estradiol induces endothelial cell migration and proliferation through estrogen receptor-enhanced RhoA\/ROCK pathway","volume":"335","author":"Oviedo","year":"2011","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib32","doi-asserted-by":"crossref","first-page":"38540","DOI":"10.1074\/jbc.M007555200","article-title":"Estrogen signals to the preservation of endothelial cell form and function","volume":"275","author":"Razandi","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib33","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1161\/CIRCULATIONAHA.112.124529","article-title":"Rapid estrogen receptor signaling is essential for the protective effects of estrogen against vascular injury","volume":"126","author":"Bernelot Moens","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib34","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s11010-012-1482-9","article-title":"Estradiol inhibits vascular endothelial cells pro-inflammatory activation induced by C-reactive protein","volume":"373","author":"Cossette","year":"2013","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib35","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1161\/ATVBAHA.109.192849","article-title":"Estrogen receptor alpha expression in both endothelium and hematopoietic cells is required for the accelerative effect of estradiol on reendothelialization","volume":"29","author":"Toutain","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib36","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jsbmb.2017.03.021","article-title":"Twenty years of the G protein-coupled estrogen receptor GPER: historical and personal perspectives","volume":"176","author":"Barton","year":"2018","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib37","doi-asserted-by":"crossref","first-page":"174363","DOI":"10.1016\/j.ejphar.2021.174363","article-title":"A review of the functions of G protein-coupled estrogen receptor 1 in vascular and neurological aging","volume":"908","author":"Yang","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib38","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.steroids.2009.12.006","article-title":"A critical review of fundamental controversies in the field of GPR30 research","volume":"75","author":"Langer","year":"2010","journal-title":"Steroids"},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib39","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jsbmb.2017.05.006","article-title":"Role of GPER in estrogen-dependent nitric oxide formation and vasodilation","volume":"176","author":"Fredette","year":"2018","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib40","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.envpol.2017.09.069","article-title":"Bisphenol A induces proliferative effects on both breast cancer cells and vascular endothelial cells through a shared GPER-dependent pathway in hypoxia","volume":"231","author":"Xu","year":"2017","journal-title":"Environ. Pollut."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib41","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1124\/jpet.116.238212","article-title":"The glycolytic enzyme PFKFB3 is involved in estrogen-mediated angiogenesis via GPER 1","volume":"361","author":"Trenti","year":"2017","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib42","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S0039-128X(99)00014-8","article-title":"The structure of the nuclear hormone receptors","volume":"64","author":"Kumar","year":"1999","journal-title":"Steroids"},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib43","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.steroids.2012.11.011","article-title":"Lessons from the dissection of the activation functions (AF-1 and AF-2) of the estrogen receptor alpha in vivo","volume":"78","author":"Arnal","year":"2013","journal-title":"Steroids"},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib44","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1152\/physrev.00024.2016","article-title":"Membrane and nuclear estrogen receptor alpha actions: from tissue specificity to medical implications","volume":"97","author":"Arnal","year":"2017","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib45","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1161\/01.RES.81.5.885","article-title":"17 beta-estradiol regulation of human endothelial cell basal nitric oxide release, independent of cytosolic Ca2+ mobilization","volume":"81","author":"Caulin-Glaser","year":"1997","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib46","first-page":"L119","article-title":"Estrogen acutely stimulates nitric oxide synthase activity in fetal pulmonary artery endothelium","volume":"273","author":"Lantin-Hermoso","year":"1997","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib47","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1161\/01.CIR.89.1.52","article-title":"Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women","volume":"89","author":"Reis","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib48","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1172\/JCI5347","article-title":"Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen","volume":"103","author":"Chen","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib49","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1210\/me.2005-0525","article-title":"Nature of functional estrogen receptors at the plasma membrane","volume":"20","author":"Pedram","year":"2006","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib50","first-page":"307","article-title":"Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: studies of ERalpha and ERbeta expressed in Chinese hamster ovary cells","volume":"13","author":"Razandi","year":"1999","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib51","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1210\/mend.16.1.0757","article-title":"ERs associate with and regulate the production of caveolin: implications for signaling and cellular actions","volume":"16","author":"Razandi","year":"2002","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib52","doi-asserted-by":"crossref","first-page":"E44","DOI":"10.1161\/01.RES.87.11.e44","article-title":"Estrogen receptor alpha and endothelial nitric oxide synthase are organized into a functional signaling module in caveolae","volume":"87","author":"Chambliss","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib53","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1091\/mbc.e04-07-0547","article-title":"Palmitoylation-dependent estrogen receptor alpha membrane localization: regulation by 17beta-estradiol","volume":"16","author":"Acconcia","year":"2005","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib54","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.bbrc.2004.02.129","article-title":"S-palmitoylation modulates human estrogen receptor-alpha functions","volume":"316","author":"Acconcia","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib55","doi-asserted-by":"crossref","first-page":"17126","DOI":"10.1073\/pnas.0407492101","article-title":"Striatin assembles a membrane signaling complex necessary for rapid, nongenomic activation of endothelial NO synthase by estrogen receptor alpha","volume":"101","author":"Lu","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib56","doi-asserted-by":"crossref","first-page":"27071","DOI":"10.1074\/jbc.M100312200","article-title":"Plasma membrane estrogen receptors are coupled to endothelial nitric-oxide synthase through G\u03b1i","volume":"276","author":"Wyckoff","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib57","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1210\/me.2006-0360","article-title":"Direct interactions with G\u03b1i and G\u03b2\u03b3 mediate nongenomic signaling by estrogen receptor alpha","volume":"21","author":"Kumar","year":"2007","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib58","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1210\/me.2011-1378","article-title":"Point mutations in the ERalpha G\u03b1i binding domain segregate nonnuclear from nuclear receptor function","volume":"27","author":"Wu","year":"2013","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib59","doi-asserted-by":"crossref","first-page":"E283","DOI":"10.1073\/pnas.1322057111","article-title":"Mutation of the palmitoylation site of estrogen receptor alpha in vivo reveals tissue-specific roles for membrane versus nuclear actions","volume":"111","author":"Adlanmerini","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib60","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1161\/ATVBAHA.120.314159","article-title":"Mutation of arginine 264 on ERalpha (estrogen receptor alpha) selectively abrogates the rapid signaling of estradiol in the endothelium without altering fertility","volume":"40","author":"Adlanmerini","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib61","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1073\/pnas.0808742106","article-title":"The transactivating function 1 of estrogen receptor alpha is dispensable for the vasculoprotective actions of 17beta-estradiol","volume":"106","author":"Billon-Gales","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib62","doi-asserted-by":"crossref","first-page":"13311","DOI":"10.1073\/pnas.1105632108","article-title":"Activation function 2 (AF2) of estrogen receptor-alpha is required for the atheroprotective action of estradiol but not to accelerate endothelial healing","volume":"108","author":"Billon-Gales","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib63","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1210\/me.2005-0186","article-title":"Estrogen dendrimer conjugates that preferentially activate extranuclear, nongenomic versus genomic pathways of estrogen action","volume":"20","author":"Harrington","year":"2006","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib64","doi-asserted-by":"crossref","first-page":"ra53","DOI":"10.1126\/scisignal.aad8170","article-title":"Design of pathway preferential estrogens that provide beneficial metabolic and vascular effects without stimulating reproductive tissues","volume":"9","author":"Madak-Erdogan","year":"2016","journal-title":"Sci. Signal."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib65","doi-asserted-by":"crossref","first-page":"15577","DOI":"10.1074\/jbc.RA119.008597","article-title":"17beta-estradiol nongenomically induces vascular endothelial H2S release by promoting phosphorylation of cystathionine gamma-lyase","volume":"294","author":"Xu","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib66","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1210\/me.2005-0259","article-title":"Estrogen receptor alpha interacts with G\u03b113 to drive actin remodeling and endothelial cell migration via the RhoA\/Rho kinase\/moesin pathway","volume":"20","author":"Simoncini","year":"2006","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib67","doi-asserted-by":"crossref","first-page":"830","DOI":"10.2353\/ajpath.2008.070439","article-title":"The estrogen effects on endothelial repair and mitogen-activated protein kinase activation are abolished in endothelial nitric-oxide (NO) synthase knockout mice, but not by no synthase inhibition by N-nitro-L-arginine methyl ester","volume":"172","author":"Billon","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib68","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1161\/hh0402.105096","article-title":"Estradiol alters nitric oxide production in the mouse aorta through the alpha-, but not beta-, estrogen receptor","volume":"90","author":"Darblade","year":"2002","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib69","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000025732","article-title":"The mitogenic effect of 17beta-estradiol on in vitro endothelial cell proliferation and on in vivo reendothelialization are both dependent on vascular endothelial growth factor","volume":"37","author":"Concina","year":"2000","journal-title":"J. Vasc. Res."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib70","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.2353\/ajpath.2006.060260","article-title":"Essential role of bone marrow fibroblast growth factor-2 in the effect of estradiol on reendothelialization and endothelial progenitor cell mobilization","volume":"169","author":"Fontaine","year":"2006","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib71","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.coph.2011.10.009","article-title":"Subcellular signaling in the endothelium: cyclic nucleotides take their place","volume":"11","author":"Maurice","year":"2011","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib72","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrd4228","article-title":"Advances in targeting cyclic nucleotide phosphodiesterases","volume":"13","author":"Maurice","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib73","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.steroids.2016.03.012","article-title":"Estradiol's interesting life at the cell's plasma membrane","volume":"111","author":"Caldwell","year":"2016","journal-title":"Steroids"},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib74","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1073\/pnas.58.4.1711","article-title":"Adenosine 3',5'-monophosphate in rat uterus: acute elevation by estrogen","volume":"58","author":"Szego","year":"1967","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib75","doi-asserted-by":"crossref","first-page":"14737","DOI":"10.1074\/jbc.R110.191791","article-title":"Non-nuclear estrogen receptor signaling in the endothelium","volume":"286","author":"Wu","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib76","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1002\/j.1460-2075.1990.tb07469.x","article-title":"Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen","volume":"9","author":"Berry","year":"1990","journal-title":"EMBO J."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib77","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa062462","article-title":"Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women","volume":"355","author":"Barrett-Connor","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib78","doi-asserted-by":"crossref","first-page":"k3845","DOI":"10.1136\/bmj.k3845","article-title":"Long term adjuvant endocrine therapy and risk of cardiovascular disease in female breast cancer survivors: systematic review","volume":"363","author":"Matthews","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib79","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1161\/01.CIR.95.6.1542","article-title":"Tamoxifen decreases cholesterol sevenfold and abolishes lipid lesion development in apolipoprotein E knockout mice","volume":"95","author":"Reckless","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib80","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ajpath.2013.03.010","article-title":"Tamoxifen elicits atheroprotection through estrogen receptor alpha AF-1 but does not accelerate reendothelialization","volume":"183","author":"Fontaine","year":"2013","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib81","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"Jama"},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib82","doi-asserted-by":"crossref","first-page":"III281","DOI":"10.1161\/circ.102.suppl_3.III-281","article-title":"Selective estrogen receptor modulator idoxifene inhibits smooth muscle cell proliferation, enhances reendothelialization, and inhibits neointimal formation in vivo after vascular injury","volume":"102","author":"Yue","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib83","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.mce.2004.08.004","article-title":"Selective estrogen receptor modulators prevent neointima formation after vascular injury","volume":"227","author":"Savolainen-Peltonen","year":"2004","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib84","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/09513590.2021.1876653","article-title":"Bazedoxifene increases the proliferation of human arterial endothelial cells but does not affect the expression of cyclins A, B, and D1 and of p27(kip1)","volume":"37","author":"Dudenko","year":"2021","journal-title":"Gynecol. Endocrinol. : the official journal of the International Society of Gynecological Endocrinology"},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib85","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1161\/CIRCRESAHA.118.314567","article-title":"Novel paracrine functions of smooth muscle cells in supporting endothelial regeneration following arterial injury","volume":"124","author":"Ren","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib86","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1161\/CIRCRESAHA.118.313374","article-title":"Smooth muscle contact drives endothelial regeneration by Bmpr2-Notch1-mediated metabolic and epigenetic changes","volume":"124","author":"Miyagawa","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib87","doi-asserted-by":"crossref","first-page":"108493","DOI":"10.1016\/j.steroids.2019.108493","article-title":"ERalpha-targeted endocrine therapy, resistance and the role of GPER","volume":"152","author":"Pepermans","year":"2019","journal-title":"Steroids"},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib88","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.vph.2011.06.003","article-title":"The G protein-coupled estrogen receptor GPER\/GPR30 as a regulator of cardiovascular function","volume":"55","author":"Meyer","year":"2011","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib89","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1210\/en.2004-1064","article-title":"Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells","volume":"146","author":"Thomas","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib90","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.maturitas.2017.07.014","article-title":"27-hydroxycholesterol, an endogenous selective estrogen receptor modulator","volume":"104","author":"He","year":"2017","journal-title":"Maturitas"},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib91","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.tem.2011.01.003","article-title":"27-hydroxycholesterol: the first identified endogenous SERM","volume":"22","author":"Umetani","year":"2011","journal-title":"Trends in endocrinology and metabolism: TEM (Trends Endocrinol. Metab.)"},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib92","doi-asserted-by":"crossref","first-page":"16536","DOI":"10.1074\/jbc.M001811200","article-title":"Disruption of the oxysterol 7alpha-hydroxylase gene in mice","volume":"275","author":"Li-Hawkins","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib93","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/nm1641","article-title":"27-hydroxycholesterol is an endogenous serm that inhibits the cardiovascular effects of estrogen","volume":"13","author":"Umetani","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib94","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.cmet.2014.05.013","article-title":"The cholesterol metabolite 27-hydroxycholesterol promotes atherosclerosis via proinflammatory processes mediated by estrogen receptor alpha","volume":"20","author":"Umetani","year":"2014","journal-title":"Cell Metabol."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib95","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.maturitas.2003.11.009","article-title":"Are all estrogens the same?","volume":"47","author":"Coelingh Bennink","year":"2004","journal-title":"Maturitas"},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib96","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.15252\/emmm.201404112","article-title":"The uterine and vascular actions of estetrol delineate a distinctive profile of estrogen receptor alpha modulation, uncoupling nuclear and membrane activation","volume":"6","author":"Abot","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib97","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/01.CIR.0000050652.47145.4C","article-title":"Age-dependent impairment of reendothelialization after arterial injury: role of vascular endothelial growth factor","volume":"107","author":"Gennaro","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2021.10.013_bib98","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1161\/CIR.0000000000000556","volume":"137","author":"Mehta","year":"2018","journal-title":"Circulation"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915021014118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915021014118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T16:26:36Z","timestamp":1762187196000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915021014118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":98,"alternative-id":["S0021915021014118"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2021.10.013","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A historical view of estrogen effect on arterial endothelial healing: From animal models to medical implication","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2021.10.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}